Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,400
Closed -$523K 1402
2024
Q2
$523K Buy
+1,400
New +$473K 0.01% 730
2023
Q2
Sell
-5,000
Closed -$2.43M 840
2023
Q1
$2.43M Buy
5,000
+4,700
+1,567% +$2.32M 0.09% 207
2022
Q4
$154K Sell
300
-200
-40% -$105K 0.01% 750
2022
Q3
$243K Buy
+500
New +$243K 0.01% 671
2018
Q4
Sell
-24,700
Closed -$8.36M 1493
2018
Q3
$8.36M Buy
24,700
+8,900
+56% +$2.89M 0.15% 94
2018
Q2
$4.7M Sell
15,800
-5,300
-25% -$1.55M 0.09% 194
2018
Q1
$5.67M Buy
+21,100
New +$5.71M 0.09% 177
2017
Q2
Sell
-65,000
Closed -$13.4M 2289
2017
Q1
$13.4M Buy
+65,000
New +$13.4M 0.16% 88

Other funds holding HUM

Paloma Partners's HUM Position: Q4 2024 in Review

Paloma Partners sold out of Humana (HUM) in Q4 2024, closing a stake of 853 shares — an estimated $270K sold.

Paloma Partners first reported a position in HUM in Q2 2013 and held it in 36 quarters. The position peaked at $12.7M in Q1 2017. 876 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

  • Paloma Partners reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 853 Humana shares in Q4 2024, an estimated $270K.
  • Paloma Partners first reported a position in Humana in Q2 2013 and held it in 36 quarters.
  • Paloma Partners's Humana position peaked at $12.7M in Q1 2017.
  • 876 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.